CancerHacker Lab

What CancerHacker Lab does

CancerHacker Lab (legal name "Cancer HackerLab Accelerator") is a privately-held, founder-owned accelerator targeting pre-seed and seed-stage founders building solutions in cancer diagnostics and patient navigation. The company operates at the intersection of science, consumer tech, and healthcare, offering cohort-based services including Growth/GTM advisory, healthcare system navigation (revenue cycle management, legal, regulatory affairs), product building mentorship, demo-day investor connections, and patient panel collaborations. The company is led by Co-Founder/CEO Ari Akerstein (a cancer survivor and former product leader at Meta/FB and IncludedHealth), Co-Founder Brad Power (also CEO of Cancer Patient Lab), and Co-Founder Scott Petinga, with a reported headcount of seven employees.

The core product surface consists of three components: (1) the CHL Community Tier, a $599-per-year subscription membership providing monthly live sessions, weekly office hours, group chat, and periodic workshops; (2) the Cancer Patient Lab, a community platform connecting patients, advocates, and doctors that doubles as a patient engagement and feedback channel for portfolio companies; and (3) the Prostate Cancer Lab, a specialized sub-community under Cancer Patient Lab focused on prostate cancer patients. The accelerator program itself is cohort-based with the next cohort scheduled for Q1 2025, but cohort pricing is not disclosed. The underlying technology is a curated accelerator and community platform with no proprietary AI or software infrastructure disclosed at the firm level; AI capability sits within portfolio companies such as REPROSENT (patient symptom data plus AI), DORIS.Health by Wild Type Advocates (oncology language model), and Hurone AI (oncology AI across developed and emerging markets).

The business model derives revenue from two streams, both described as subscription-style: the $599/year CHL Community Tier membership and the (undisclosed) cohort-based accelerator program. The company appears bootstrapped with no disclosed venture funding, no parent company, and no institutional investors identified in source material. No revenue figures, headcount history, contract values, or operating geographies are disclosed beyond a global website channel. The customer base is bifurcated between pre-seed/seed founders (the accelerator cohort) and individual cancer patients (free access via Cancer Patient Lab), supported by a 15+ company portfolio spanning cancer diagnostics, navigation, AI, and genomics.

Name

CancerHacker Lab

Legal name

Cancer HackerLab Accelerator

Website

https://cancerhackerlab.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

CancerHacker Lab is a privately-held, founder-owned accelerator serving pre-seed and seed-stage founders in cancer diagnostics and navigation through cohort-based programs, a $599/year community membership, and the Cancer Patient Lab patient engagement platform.

Ownership category

akta.pro rank

Product category

Healthcare Startup Accelerator

NAICS

Other Scientific and Technical Consulting Services (54169), Computer Systems Design and Related Services (54151)

SIC

Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Oncology Pathways & Precision Medicine Decision Support (HLACAGAH)

akta.pro secondary industry

Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD)

Keywords

• Cancer diagnostics accelerator
• Oncology startup programs
• Patient navigation platforms
• Healthcare founder communities
• Venture support services

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. CHL Community Tier Subscription: Annual subscription at $599 per year providing access to monthly live sessions, weekly office hours, group chat, and periodic workshops.
2. Accelerator Program: Cohort-based accelerator program supporting pre-seed/seed-stage founders in cancer diagnostics and navigation. Generates value through portfolio company success and demo day investor connections.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels3 records

Core offering

CancerHacker Lab operates a curated accelerator and community program for pre-seed and seed-stage founders building solutions in cancer diagnostics and patient navigation. The core deliverable is cohort-based accelerator support offering Growth/GTM mentorship, healthcare navigation advisory (revenue cycle, legal, regulatory), product-building mentorship from consumer tech leaders, demo day investor connections, and patient panel collaborations through the affiliated Cancer Patient Lab. A separate annual CHL Community Tier subscription at $599/year provides ongoing access to monthly live sessions, weekly office hours, group chat, and workshops for cancer-focused founders.

Product overview

CancerHacker Lab operates as a curated accelerator program rather than a single product. The company provides a community-based membership tier (CHL Community Tier) paired with patient engagement platforms (Cancer Patient Lab, Prostate Cancer Lab) that connect founders with patients, advocates, and physicians. The accelerator offers services including Growth/GTM guidance, healthcare navigation advisory, product building mentorship, investment connections via demo days, and patient panel collaborations. The program targets pre-seed and seed-stage founders building solutions in cancer diagnostics and navigation.

Differentiator

Problem solved

Functional benefit

Products and services

• CHL Community Tier Annual subscription membership offering monthly live sessions, weekly office hours, group chat, and periodic workshops for cancer diagnostics and navigation founders. Billed every 12 months at $599.00.
• Cancer Patient Lab A community platform connecting Patients, Advocates, and Doctors to facilitate early exposure to disruptive changes in cancer care, foster lasting relationships, and boost brand awareness for cancer solution companies.
• Prostate Cancer Lab Specialized sub-community under Cancer Patient Lab focused on prostate cancer patients, providing education and support for navigating treatment options including access to proteomic testing.
• CHL Accelerator Program Cohort-based accelerator program for pre-seed/seed-stage founders in cancer diagnostics and navigation. Provides Growth/GTM support (B2B, D2C, Pharma partnerships), healthcare navigation advisory (revenue cycle, legal, regulatory affairs), product building mentorship from consumer tech leaders, investment connections via demo day, and patient panel collaborations. The next cohort kicks off in Q1 2025 with applications managed through an email list.

Named customers8 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

15 partnerships are on record.

• SageMedicOthersPortfolio company founded by Chris Apfel, MD, PhD, MBA. California-licensed physician, clinical researcher with 100+ publications including NEJM, impact investor, board member and advisor to life science startups. Part of CancerHacker Lab accelerator portfolio.
• Aware CoachingOthersPortfolio company founded by Jason Binder, dedicated to helping couples survive and grow from the trauma of brain cancer. Founded after Tracy Binder was diagnosed with glioblastoma in February 2022.
• REPROSENTOthersPortfolio company transforming cancer care with patient symptom data and AI. YC S21 company capturing longitudinal patient symptom data for continuous process improvement.
• Wild Type AdvocatesOthersPortfolio company with DORIS.Health AI oncology platform. Co-founded by Dave Holecek with 25+ years biotech commercialization experience. Building oncology-specific language model DORIS.
• We Are HereOthersPortfolio company by Carolyn Trevino Jenkins, Techstars Health '24 graduate. Cancer advocate company with focus on special needs and meaningful connections.
• Research to the PeopleOthersPortfolio company at Stanford Medicine founded by Peter Kane, focused on making research accessible to patients.
• Rabble HealthOthersPortfolio company by Aubrey Kelly, MS, MBA. Digital health company helping people facing complex disease gain access to innovation in medicine. Advocacy Board Chair at Children's Hospital Los Angeles.
• Protean BioDiagnosticsOthersPortfolio company led by Dr. Anthony M. Magliocco, MD FRCPC FCAP. Board-certified Pathologist and Professor of Oncology with 30+ years experience in tissue pathology and molecular diagnostics.
• Nine DiagnosticsOthersPortfolio company by Freddy Nguyen, MD/PhD, Physician-Scientist Fellow at MIT. Developing biomedical optical technologies and nanotechnologies from bench to bedside in oncology.
• Translating Science PBCOthersPortfolio company by Frank Austin Nothaft, PhD. Building tools to help patients understand their genomic test results. Previously led Lens platform at Tempus Labs and Healthcare/Life Sciences team at Databricks.
• Genomic ExpressionOthersPortfolio company by Gitte Pedersen. Launching RNA Platform OneRNA for treatment navigation diagnostic tool in breast and ovarian cancer. 99% diagnostic yield. Raised $6.5M in grants, $4.5M lifetime revenue, $1.7M convertible notes.
• DatAnonOthersPortfolio company by Ryan Ramanujam, PhD, Associate Professor at Karolinska Institute. Using novel topological data analysis tools for precision oncology to detect subgroups of patient responders.
• Sagely HealthOthersPortfolio company by Jason Sager, MD, career physician-scientist with 12 years clinical experience at Johns Hopkins, NCI, Dana Farber. Health IT company helping cancer patients identify innovative therapies and personalized care.
• Vivan TherapeuticsOthersPortfolio company by Laura Towart, PhD, CEO. Personalized cancer approach developed at Mt Sinai Medical Center with proprietary whole organism disease modeling and high throughput drug screening platform.
• Hurone AIOthersPortfolio company by Kingsley Ndoh, MD, MPH. AI-driven technologies transforming cancer care across developed and emerging markets. Strategic partnerships with UCSF Brain Tumor Center, Johns Hopkins Sidney Kimmel Cancer Center, and National Cancer Institute of Kenya.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• IndieBio: IndieBio runs a biotech accelerator backing early-stage founders in life sciences and health, with portfolio overlap in oncology, diagnostics, and AI-driven biology — a close functional comparator to CancerHacker Lab's accelerator.
• Techstars Healthcare: Techstars runs healthcare-focused accelerator programs (including Techstars Health) that support early-stage digital health and biotech founders, directly comparable to CancerHacker Lab's accelerator + mentorship model in healthcare.
• Matter Health: Chicago-based healthtech accelerator offering mentorship, partnerships, and community to early-stage healthcare companies, directly comparable as a healthcare-focused accelerator with cohort programs.
• Cedars-Sinai Accelerator: Hospital-affiliated health-tech accelerator providing mentorship and clinical access to early-stage healthcare founders; comparable in mission to CancerHacker Lab's clinical and patient-network-enabled model.

Emerging players

• Cancer Commons: Non-profit cancer navigation and precision oncology decision support organization, with mission overlap to CancerHacker Lab's emphasis on patient-centered cancer care and diagnostic error reduction.
• Massive Bio: Clinical trial matching and cancer patient navigation company, comparable to the navigation and clinical-trial-access functions supported through Cancer Patient Lab and Prostate Cancer Lab.
• Outcomes4Me: AI-driven cancer patient navigation and clinical trial matching platform; overlaps with CancerHacker Lab's Cancer Patient Lab mission of helping patients access personalized treatment and trials.

Broad incumbents

• Y Combinator: Y Combinator is the largest general-purpose accelerator; its healthcare and bio tracks (e.g., YC S21 alumni REPROSENT in CHL's portfolio) overlap with CancerHacker Lab's thesis on cancer diagnostics and AI-driven oncology.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/cancerhacker-lab

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CancerHacker Lab